Autologous Stem Cell and Non-stem Cell Based Therapies Market size is expected to reach nearly US$ 10.82 Bn. by 2029 with the CAGR of 14.2% during the forecast period.Autologous stem cell and Non-stem cell based Therapies Market Overview
Regenerative medicine is now a global venture. Fresh ideas, advanced technologies and an increasing need, continue to revitalize and strengthen the interest of investors in this market. Autologous Stem cell Therapy is changing medical treatments by introducing new therapies. The market has a vast scope and a promising future over standard therapies. Autologous stem cell and non-autologous stem cell based therapies are considered to be safer and effective in comparison with other transplant therapies. Autologous transplants reduce the risks of disease transmission, bio-incompatibility and immunological reactions.To know about the Research Methodology :- Request Free Sample Report Healthcare regulatory bodies are expecting companies to develop therapy treatments that are safer, affordable and easy to use. Autologous Stem cell transplantation therapy is safe to use, has minimum number of steps to follow and is rapid in delivering results. These characteristics of the therapy are helping the market growth. The sources for ACT are mesenchymal stem cells, haematopoietic stem cells and chondrocytes. ACT has been successful in treatment of cancer, cosmetic surgeries, skin burns etc. Hence, this technology is expected to provide huge opportunities for investors and manufacturers in the global market. However, the current cost for this therapy is not affordable and is a major restraint for the market. The report provides a detailed analysis about the autologous and non-autologous stem cell based therapies market. It includes the recent advances, applications and ongoing trends globally. Funding for treatments, partnerships between key players, revenue forecasts of companies are also provided in detail in the report. The report also provides information on application areas to help investors invest rightly. The report has profiled twenty three key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
Autologous stem cell and Non-stem cell based Therapies Market Segment Analysis
Cancer holds a significant share in the Autologous and Non-autologous stem cell based therapies market The increasing prevalence of cancer globally is a major concern. According to WHO, cancer was responsible for about 9.6 million deaths globally in 2022. Approximately 70% of deaths from cancer occur in low and middle-income countries. The most common causes of cancer death are lung cancer, stomach cancer, colorectal cancer etc. Autologous stem cell transplant’s goal is to restore the body’s ability to make normal blood cells after doses of radiation or chemotherapy. The Autologous transplantation therapy uses the “Engraftment” technique and is quicker than an allogeneic transplant. The market for ACT and non-ACT based therapies is expected to grow at a CAGR of xx% during the forecast period, owing to its wide range applications and promising results. Increasing hypertension globally leads to an increase in demand for home monitoring devices The blood pressure monitoring devices of product segment are expected to gain momentum in the forecast period, thereby driving the market for ACT and non-ACT based therapies. Advancements in mobile based BP monitoring systems, wearable and portable devices are gaining popularity and are positively impacting the market growth. Benefit of automated devices such as repetitive measurements of BP with accuracy is contributing to market growth. These devices are available in various forms, including arm, wrist and finger for measurement of blood pressure.Regional Insights
North America dominates the Autologous Stem cells and Non-Autologous stem cell based therapies market. North America dominated the stem cell market contributing to the largest share of xx% in the market. The availability of funds from various organizations and presence of key players in the region is encouraging investors to invest more. Various stem cell studies across the US are helping the market to accelerate. In SA and NA, treatments through ACT and non-ACT based therapies for diabetes and other diseases are actively progressing. European countries are also actively engaged in the development of ACT and non-ACT based therapies. In developing nations of the APAC region large investments are being made for stem cell therapies, which is expected to drive the market growth.Autologous stem cell and Non-stem cell based Therapies Market Scope : Inquire before buying
Autologous stem cell and Non-stem cell based Therapies Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 4.27 Bn. Forecast Period 2023 to 2029 CAGR: 14.2% Market Size in 2029: US $ 10.82 Bn. Segments Covered: by Product Neurodegenerative disorders Autoimmune diseases Cancer and Tumours Cardiovascular Diseases by Type Blood Pressure monitoring devices Pulmonary pressure monitoring devices Intracranial pressure monitoring devices by Application Hospitals Ambulatory surgical centers Others Key Players:
1. Fibrocell Science, Inc 2. Astrom Biosciences 3. Dendreon Corporation 4. NeoStem, Inc 5. Brainstorm Cell therapeutics 6. Regeneus Ltd 7. Genzyme Corporation 8. Antria 9. Bioheart 10. Cytori Therapeutics 11. Genesis Biopharma 12. Opexa Therapeutics 13. Orgenesis 14. Regenexx 15. Tengion 16. Sanofi 17. Mesoblast Ltd 18. Virxsys 19. StemGeneXamong 20. Vericel Corporation 21. Med Cell Europe AG 22. IovanceBiotherapeutics Inc Frequently Asked Questions: 1. Which region has the largest share in Global Autologous stem cell and non-autologous stem cell Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Autologous stem cell and non-autologous stem cell Market? Ans: The Global Autologous stem cell and non-autologous stem cell Market is growing at a CAGR of 14.2% during forecasting period 2023-2029. 3. What is scope of the Global Autologous stem cell and non-autologous stem cell market report? Ans: Global Autologous stem cell and non-autologous stem cell Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Autologous stem cell and non-autologous stem cell market? Ans: The important key players in the Global Autologous stem cell and non-autologous stem cell Market are – Fibrocell Science, Inc, Astrom Biosciences, Dendreon Corporation, NeoStem, Inc, Brainstorm Cell therapeutics, Regeneus Ltd, Genzyme Corporation, 5. What is the study period of this market? Ans: The Global Autologous stem cell and non-autologous stem cell Market is studied from 2022 to 2029.
Global Autologous stem cell and Non-stem cell based Therapies Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: GOLBAL AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis and Forecast 6.1. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis and Forecast, By Applications 7.1. Introduction and Definition 7.2. Key Findings 7.3. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications 7.4. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size (US$ Mn) Forecast, By Applications 7.5. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Applications 7.6. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis, By Applications 8. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis and Forecast, By Products 8.1. Introduction and Definition 8.2. Key Findings 8.3. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products 8.4. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size (US$ Mn) Forecast, By Products 8.5. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Products 8.6. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis, By Products 9. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis and Forecast By End-users 9.1. Introduction and Definition 9.2. Key Findings 9.3. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users 9.4. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size (US$ Mn) Forecast, By End-users 9.5. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By End-users 9.6. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis, By End-users 10. Global AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Region 10.1. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Region 10.2. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Size (US$ Mn) Forecast, By Region 10.3. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis, By Region 11. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis 11.1. Key Findings 11.2. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview 11.3. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications 11.4. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 11.4.1. Neurodegenerative disorders 11.4.2. Autoimmune diseases 11.4.3. Cancer and Tumors 11.4.4. Cardiovascular Diseases 11.5. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products 11.6. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 11.6.1. Blood Pressure monitoring devices 11.6.2. Pulmonary pressure monitoring devices 11.6.3. Intracranial pressure monitoring devices 11.7. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users 11.8. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 11.8.1. Hospitals 11.8.2. Ambulatory surgical centers 11.8.3. Others 11.9. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country 11.10. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Country 11.12. U.S. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 11.12.1. Neurodegenerative disorders 11.12.2. Autoimmune diseases 11.12.3. Cancer and Tumors 11.12.4. Cardiovascular Diseases 11.13. U.S. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 11.13.1. Blood Pressure monitoring devices 11.13.2. Pulmonary pressure monitoring devices 11.13.3. Intracranial pressure monitoring devices 11.14. U.S. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 11.14.1. Hospitals 11.14.2. Ambulatory surgical centers 11.14.3. Others 11.15. Canada AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 11.15.1. Neurodegenerative disorders 11.15.2. Autoimmune diseases 11.15.3. Cancer and Tumors 11.15.4. Cardiovascular Diseases 11.16. Canada AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 11.16.1. Blood Pressure monitoring devices 11.16.2. Pulmonary pressure monitoring devices 11.16.3. Intracranial pressure monitoring devices 11.17. Canada AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 11.17.1. Hospitals 11.17.2. Ambulatory surgical centers 11.17.3. Others 11.18. Mexico AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 11.18.1. Neurodegenerative disorders 11.18.2. Autoimmune diseases 11.18.3. Cancer and Tumors 11.18.4. Cardiovascular Diseases 11.19. Mexico AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 11.19.1. Blood Pressure monitoring devices 11.19.2. Pulmonary pressure monitoring devices 11.19.3. Intracranial pressure monitoring devices 11.20. Mexico AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 11.20.1. Hospitals 11.20.2. Ambulatory surgical centers 11.20.3. Others 11.21. North America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis 11.21.1. By Applications 11.21.2. By Products 11.21.3. By End-users 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis 12.1. Key Findings 12.2. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview 12.3. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications 12.4. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.4.1. Neurodegenerative disorders 12.4.2. Autoimmune diseases 12.4.3. Cancer and Tumors 12.4.4. Cardiovascular Diseases 12.5. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products 12.6. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.6.1. Blood Pressure monitoring devices 12.6.2. Pulmonary pressure monitoring devices 12.6.3. Intracranial pressure monitoring devices 12.7. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users 12.8. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.8.1. Hospitals 12.8.2. Ambulatory surgical centers 12.8.3. Others 12.9. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country 12.10. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Germany AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.11.1. Neurodegenerative disorders 12.11.2. Autoimmune diseases 12.11.3. Cancer and Tumors 12.11.4. Cardiovascular Diseases 12.12. Germany AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.12.1. Blood Pressure monitoring devices 12.12.2. Pulmonary pressure monitoring devices 12.12.3. Intracranial pressure monitoring devices 12.13. Germany AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.13.1. Hospitals 12.13.2. Ambulatory surgical centers 12.13.3. Others 12.14. U.K. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.14.1. Neurodegenerative disorders 12.14.2. Autoimmune diseases 12.14.3. Cancer and Tumors 12.14.4. Cardiovascular Diseases 12.15. U.K. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.15.1. Blood Pressure monitoring devices 12.15.2. Pulmonary pressure monitoring devices 12.15.3. Intracranial pressure monitoring devices 12.16. U.K. AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.16.1. Hospitals 12.16.2. Ambulatory surgical centers 12.16.3. Others 12.17. France AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.17.1. Neurodegenerative disorders 12.17.2. Autoimmune diseases 12.17.3. Cancer and Tumors 12.17.4. Cardiovascular Diseases 12.18. France AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.18.1. Blood Pressure monitoring devices 12.18.2. Pulmonary pressure monitoring devices 12.18.3. Intracranial pressure monitoring devices 12.19. France AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.19.1. Hospitals 12.19.2. Ambulatory surgical centers 12.19.3. Others 12.20. Italy AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.20.1. Neurodegenerative disorders 12.20.2. Autoimmune diseases 12.20.3. Cancer and Tumors 12.20.4. Cardiovascular Diseases 12.21. Italy AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.21.1. Blood Pressure monitoring devices 12.21.2. Pulmonary pressure monitoring devices 12.21.3. Intracranial pressure monitoring devices 12.22. Italy AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.22.1. Hospitals 12.22.2. Ambulatory surgical centers 12.22.3. Others 12.23. Spain AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.23.1. Neurodegenerative disorders 12.23.2. Autoimmune diseases 12.23.3. Cancer and Tumors 12.23.4. Cardiovascular Diseases 12.24. Spain AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.24.1. Blood Pressure monitoring devices 12.24.2. Pulmonary pressure monitoring devices 12.24.3. Intracranial pressure monitoring devices 12.25. Spain AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.25.1. Hospitals 12.25.2. Ambulatory surgical centers 12.25.3. Others 12.26. Sweden AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.26.1. Neurodegenerative disorders 12.26.2. Autoimmune diseases 12.26.3. Cancer and Tumors 12.26.4. Cardiovascular Diseases 12.27. Sweden AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.27.1. Blood Pressure monitoring devices 12.27.2. Pulmonary pressure monitoring devices 12.27.3. Intracranial pressure monitoring devices 12.28. Sweden AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.28.1. Hospitals 12.28.2. Ambulatory surgical centers 12.28.3. Others 12.29. CIS countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.29.1. Neurodegenerative disorders 12.29.2. Autoimmune diseases 12.29.3. Cancer and Tumors 12.29.4. Cardiovascular Diseases 12.30. CIS countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.30.1. Blood Pressure monitoring devices 12.30.2. Pulmonary pressure monitoring devices 12.30.3. Intracranial pressure monitoring devices 12.31. CIS countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.31.1. Hospitals 12.31.2. Ambulatory surgical centers 12.31.3. Others 12.32. Rest of Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 12.32.1. Neurodegenerative disorders 12.32.2. Autoimmune diseases 12.32.3. Cancer and Tumors 12.32.4. Cardiovascular Diseases 12.33. Rest of Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 12.33.1. Blood Pressure monitoring devices 12.33.2. Pulmonary pressure monitoring devices 12.33.3. Intracranial pressure monitoring devices 12.34. Rest of Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 12.34.1. Hospitals 12.34.2. Ambulatory surgical centers 12.34.3. Others 12.35. Europe AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis 12.35.1. By Products 12.35.2. By Applications 12.35.3. By End-users 12.36. PEST Analysis 12.37. Key Trends 12.38. Key Developments 13. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis 13.1. Key Findings 13.2. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview 13.3. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications 13.4. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 13.4.1. Neurodegenerative disorders 13.4.2. Autoimmune diseases 13.4.3. Cancer and Tumors 13.4.4. Cardiovascular Diseases 13.5. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products 13.6. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 13.6.1. Blood Pressure monitoring devices 13.6.2. Pulmonary pressure monitoring devices 13.6.3. Intracranial pressure monitoring devices 13.7. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users 13.8. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 13.8.1. Hospitals 13.8.2. Ambulatory surgical centers 13.8.3. Others 13.9. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country 13.10. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Country 13.12. China AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 13.12.1. Neurodegenerative disorders 13.12.2. Autoimmune diseases 13.12.3. Cancer and Tumors 13.12.4. Cardiovascular Diseases 13.13. China AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 13.13.1. Blood Pressure monitoring devices 13.13.2. Pulmonary pressure monitoring devices 13.13.3. Intracranial pressure monitoring devices 13.14. China AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 13.14.1. Hospitals 13.14.2. Ambulatory surgical centers 13.14.3. Others 13.15. India AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 13.15.1. Neurodegenerative disorders 13.15.2. Autoimmune diseases 13.15.3. Cancer and Tumors 13.15.4. Cardiovascular Diseases 13.16. India AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 13.16.1. Blood Pressure monitoring devices 13.16.2. Pulmonary pressure monitoring devices 13.16.3. Intracranial pressure monitoring devices 13.17. India AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 13.17.1. Hospitals 13.17.2. Ambulatory surgical centers 13.17.3. Others 13.18. Japan AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 13.18.1. Neurodegenerative disorders 13.18.2. Autoimmune diseases 13.18.3. Cancer and Tumors 13.18.4. Cardiovascular Diseases 13.19. Japan AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 13.19.1. Blood Pressure monitoring devices 13.19.2. Pulmonary pressure monitoring devices 13.19.3. Intracranial pressure monitoring devices 13.20. Japan AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 13.20.1. Hospitals 13.20.2. Ambulatory surgical centers 13.20.3. Others 13.21. South Korea AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 13.21.1. Neurodegenerative disorders 13.21.2. Autoimmune diseases 13.21.3. Cancer and Tumors 13.21.4. Cardiovascular Diseases 13.22. South Korea AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 13.22.1. Blood Pressure monitoring devices 13.22.2. Pulmonary pressure monitoring devices 13.22.3. Intracranial pressure monitoring devices 13.23. South Korea AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 13.23.1. Hospitals 13.23.2. Ambulatory surgical centers 13.23.3. Others 13.24. Australia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 13.24.1. Neurodegenerative disorders 13.24.2. Autoimmune diseases 13.24.3. Cancer and Tumors 13.24.4. Cardiovascular Diseases 13.25. Australia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 13.25.1. Blood Pressure monitoring devices 13.25.2. Pulmonary pressure monitoring devices 13.25.3. Intracranial pressure monitoring devices 13.26. Australia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 13.26.1. Hospitals 13.26.2. Ambulatory surgical centers 13.26.3. Others 13.27. ASEAN AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 13.27.1. Neurodegenerative disorders 13.27.2. Autoimmune diseases 13.27.3. Cancer and Tumors 13.27.4. Cardiovascular Diseases 13.28. ASEAN AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 13.28.1. Blood Pressure monitoring devices 13.28.2. Pulmonary pressure monitoring devices 13.28.3. Intracranial pressure monitoring devices 13.29. ASEAN AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 13.29.1. Hospitals 13.29.2. Ambulatory surgical centers 13.29.3. Others 13.30. Rest of Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 13.30.1. Neurodegenerative disorders 13.30.2. Autoimmune diseases 13.30.3. Cancer and Tumors 13.30.4. Cardiovascular Diseases 13.31. Rest of Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 13.31.1. Blood Pressure monitoring devices 13.31.2. Pulmonary pressure monitoring devices 13.31.3. Intracranial pressure monitoring devices 13.32. Rest of Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 13.32.1. Hospitals 13.32.2. Ambulatory surgical centers 13.32.3. Others 13.33. Asia Pacific AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis 13.33.1. By Applications 13.33.2. By Products 13.33.3. By End-users 13.34. PEST Analysis 13.35. Key Trends 13.36. Key Developments 14. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis 14.1. Key Findings 14.2. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview 14.3. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications 14.4. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 14.4.1. Neurodegenerative disorders 14.4.2. Autoimmune diseases 14.4.3. Cancer and Tumors 14.4.4. Cardiovascular Diseases 14.5. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products 14.6. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 14.6.1. Blood Pressure monitoring devices 14.6.2. Pulmonary pressure monitoring devices 14.6.3. Intracranial pressure monitoring devices 14.7. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users 14.8. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 14.8.1. Hospitals 14.8.2. Ambulatory surgical centers 14.8.3. Others 14.9. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country 14.10. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Country 14.12. GCC Countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 14.12.1. Neurodegenerative disorders 14.12.2. Autoimmune diseases 14.12.3. Cancer and Tumors 14.12.4. Cardiovascular Diseases 14.13. GCC Countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 14.13.1. Blood Pressure monitoring devices 14.13.2. Pulmonary pressure monitoring devices 14.13.3. Intracranial pressure monitoring devices 14.14. GCC Countries AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 14.14.1. Hospitals 14.14.2. Ambulatory surgical centers 14.14.3. Others 14.15. South Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 14.15.1. Neurodegenerative disorders 14.15.2. Autoimmune diseases 14.15.3. Cancer and Tumors 14.15.4. Cardiovascular Diseases 14.16. South Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 14.16.1. Blood Pressure monitoring devices 14.16.2. Pulmonary pressure monitoring devices 14.16.3. Intracranial pressure monitoring devices 14.17. South Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 14.17.1. Hospitals 14.17.2. Ambulatory surgical centers 14.17.3. Others 14.18. Nigeria AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 14.18.1. Neurodegenerative disorders 14.18.2. Autoimmune diseases 14.18.3. Cancer and Tumors 14.18.4. Cardiovascular Diseases 14.19. Nigeria AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 14.19.1. Blood Pressure monitoring devices 14.19.2. Pulmonary pressure monitoring devices 14.19.3. Intracranial pressure monitoring devices 14.20. Nigeria AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 14.20.1. Hospitals 14.20.2. Ambulatory surgical centers 14.20.3. Others 14.21. Egypt AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 14.21.1. Neurodegenerative disorders 14.21.2. Autoimmune diseases 14.21.3. Cancer and Tumors 14.21.4. Cardiovascular Diseases 14.22. Egypt AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 14.22.1. Blood Pressure monitoring devices 14.22.2. Pulmonary pressure monitoring devices 14.22.3. Intracranial pressure monitoring devices 14.23. Egypt AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 14.23.1. Hospitals 14.23.2. Ambulatory surgical centers 14.23.3. Others 14.24. Rest of Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 14.24.1. Neurodegenerative disorders 14.24.2. Autoimmune diseases 14.24.3. Cancer and Tumors 14.24.4. Cardiovascular Diseases 14.25. Rest of Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 14.25.1. Blood Pressure monitoring devices 14.25.2. Pulmonary pressure monitoring devices 14.25.3. Intracranial pressure monitoring devices 14.26. Rest of Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 14.26.1. Hospitals 14.26.2. Ambulatory surgical centers 14.26.3. Others 14.27. Middle East & Africa AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis 14.27.1. By Applications 14.27.2. By Products 14.27.3. By End-users 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis 15.1. Key Findings 15.2. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Overview 15.3. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Applications 15.4. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 15.4.1. Neurodegenerative disorders 15.4.2. Autoimmune diseases 15.4.3. Cancer and Tumors 15.4.4. Cardiovascular Diseases 15.5. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Products 15.6. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 15.6.1. Blood Pressure monitoring devices 15.6.2. Pulmonary pressure monitoring devices 15.6.3. Intracranial pressure monitoring devices 15.7. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By End-users 15.8. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 15.8.1. Hospitals 15.8.2. Ambulatory surgical centers 15.8.3. Others 15.9. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Value Share Analysis, By Country 15.10. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Country 15.10.1. Brazil 15.10.2. Colombia 15.10.3. Argentina 15.10.4. Rest of South America 15.11. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Analysis, By Country 15.12. Brazil AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 15.12.1. Neurodegenerative disorders 15.12.2. Autoimmune diseases 15.12.3. Cancer and Tumors 15.12.4. Cardiovascular Diseases 15.13. Brazil AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 15.13.1. Blood Pressure monitoring devices 15.13.2. Pulmonary pressure monitoring devices 15.13.3. Intracranial pressure monitoring devices 15.14. Brazil AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 15.14.1. Hospitals 15.14.2. Ambulatory surgical centers 15.14.3. Others 15.15. Colombia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 15.15.1. Neurodegenerative disorders 15.15.2. Autoimmune diseases 15.15.3. Cancer and Tumors 15.15.4. Cardiovascular Diseases 15.16. Colombia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 15.16.1. Blood Pressure monitoring devices 15.16.2. Pulmonary pressure monitoring devices 15.16.3. Intracranial pressure monitoring devices 15.17. Colombia AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 15.17.1. Hospitals 15.17.2. Ambulatory surgical centers 15.17.3. Others 15.18. Argentina AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 15.18.1. Neurodegenerative disorders 15.18.2. Autoimmune diseases 15.18.3. Cancer and Tumors 15.18.4. Cardiovascular Diseases 15.19. Argentina AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 15.19.1. Blood Pressure monitoring devices 15.19.2. Pulmonary pressure monitoring devices 15.19.3. Intracranial pressure monitoring devices 15.20. Argentina AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 15.20.1. Hospitals 15.20.2. Ambulatory surgical centers 15.20.3. Others 15.21. Rest of South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Applications 15.21.1. Neurodegenerative disorders 15.21.2. Autoimmune diseases 15.21.3. Cancer and Tumors 15.21.4. Cardiovascular Diseases 15.22. Rest of South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By Products 15.22.1. Blood Pressure monitoring devices 15.22.2. Pulmonary pressure monitoring devices 15.22.3. Intracranial pressure monitoring devices 15.23. Rest of South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Forecast, By End-users 15.23.1. Hospitals 15.23.2. Ambulatory surgical centers 15.23.3. Others 15.24. South America AUTOLOGOUS STEM CELL AND NON-AUTOLOGOUS STEM CELL Market Attractiveness Analysis 15.24.1. By Applications 15.24.2. By Products 15.24.3. By End-users 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, By Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players By price, presence, market share, Products, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A By Regions, Investment and Products 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Fibrocell Science, Inc 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Astrom Biosciences 16.3.3. Dendreon Corporation 16.3.4. NeoStem, Inc 16.3.5. Brainstorm Cell therapeutics 16.3.6. Regeneus Ltd 16.3.7. Genzyme Corporation 16.3.8. Antria 16.3.9. Bioheart 16.3.10. Cytori Therapeutics 16.3.11. Genesis Biopharma 16.3.12. Opexa Therapeutics 16.3.13. Orgenesis 16.3.14. Regenexx 16.3.15. Tengion 16.3.16. Sanofi 16.3.17. Mesoblast Ltd 16.3.18. Virxsys 16.3.19. StemGeneXamong 16.3.20. Vericel Corporation 16.3.21. Med Cell Europe AG 16.3.22. IovanceBiotherapeutics Inc